scispace - formally typeset
D

David Baltimore

Researcher at California Institute of Technology

Publications -  882
Citations -  168784

David Baltimore is an academic researcher from California Institute of Technology. The author has contributed to research in topics: RNA & Virus. The author has an hindex of 203, co-authored 876 publications receiving 162955 citations. Previous affiliations of David Baltimore include Thomas Jefferson University & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Effect of Fv-1 gene product on synthesis of N-tropic and B-tropic murine leukemia viral RNA

TL;DR: The data show that virus-specific RNA levels are reduced in cells nonpermissive at the Fv-1 locus, suggesting that restriction of the F v-1 gene product occurs at the level of transcription of the viral genome or at a pre-integration step, or that the RNA transcripts are rapidly degraded after their synthesis.
Journal ArticleDOI

Localization of the Abelson murine leukemia virus protein in a detergent-insoluble subcellular matrix: architecture of the protein.

TL;DR: There was an apparent movement of P120 from the Detergent-insoluble matrix to the detergent-soluble fraction and a concomitant loss of enzymatic activity.
Journal ArticleDOI

Conversion of Danger Signals into Cytokine Signals By Hematopoietic Stem and Progenitor Cells for Regulation of Stress-Induced Hematopoiesis

TL;DR: An important property of HSPCs is uncovered that enables them to convert danger signals into versatile cytokine signals for the regulation of stress-induced hematopoiesis and is uncovered in a novel single-cell proteomic platform and mouse genetic models.
Patent

Method of targeted gene delivery using viral vectors

TL;DR: In this paper, methods and compositions for delivering a polynucleotide encoding a gene of interest to a target cell using a virus are provided. But, the methods and related compositions can be used for treating patients having suffering from a wide range of conditions, including infection, such as HIV; cancers, which include non-Hodgkin's lymphoma and breast cancer; and hematological disorders, including severe combined immunodeficiency.